Therefore, when radiotherapy is combined with immune checkpoint inhibitors (such as anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA4 antibody), T cell activity directed against tumor cells can be increased. The gene discussed is CD274; the disease is neoplasm.